Rochester, MNNCT05462587Now EnrollingIRB Ready

Leukocyte Adhesion Deficiency Clinical Trial in Rochester, MN

Access cutting-edge leukocyte adhesion deficiency treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by AUG Therapeutics

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access leukocyte adhesion deficiency specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related leukocyte adhesion deficiency treatment provided free

Apply for This Rochester Location

Check if you qualify for this leukocyte adhesion deficiency clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Leukocyte Adhesion Deficiency Study in Rochester

The primary objective of this study is to evaluate the efficacy and safety of AVTX-803 compared to withdrawal in patients with Leukocyte Adhesion Deficiency, Type II (LAD II).

Sponsor: AUG Therapeutics

Who Can Participate

Inclusion Criteria

Subject must be between 6 months and 75 years old
Subject has biochemically and genetically proven LAD II (SLC35C1-CDG)
Subject has a documented history of Lewis antigen deficiency
Subject has a history of recurrent infections, opportunistic infections or infections that did not respond well to standard of care treatment
Subject or parent (for subjects under legal age for consent) has provided written informed consent for this study. Additionally, written informed assent has been provided, as appropriate, for minors of older age, per local institutional review board (IRB)/ethics committee (EC) policy and requirements
Subject is willing and able to comply with the protocol
Women of childbearing potential (WOCBP) meeting the criteria below:
Non-lactating and has a negative pregnancy test at screening -AND-
Uses an acceptable double-barrier method of contraception as determined by the investigator or sub-investigator for the duration of the study and 30 days following the last dose of study drug.
Male subjects must agree to use an acceptable double-barrier method of contraception with their partner as determined by the investigator or sub-investigator for the duration of the study and 30 days following the last dose of study drug.

Exclusion Criteria

Subject has severe anemia defined as hemoglobin \<8.0 g/dL (\<4.9 mmol/L)
Subject has impaired renal function as defined by an eGFR \<90 mL/min
Subject has a total absence of fucosylation on red blood cells and the presence of anti-H antigen
Subject has known or suspected intolerance or hypersensitivity to fucose or any ingredients of the investigational product
In the investigator's opinion, subject has a history of failure to respond to fucose at adequate dosing
In the investigator's opinion, subject is not able or not willing to comply with the study requirements.
Subject is pregnant

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT05462587) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Leukocyte Adhesion Deficiency Treatment Options in Rochester, MN

If you're searching for leukocyte adhesion deficiency treatment options in Rochester, MN, this clinical trial (NCT05462587) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leukocyte adhesion deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all leukocyte adhesion deficiency clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Rochester, MN

See all alzheimers disease clinical trials recruiting in Rochester — not just this study.

Browse Alzheimers Disease Trials in Rochester →

Browse More Trials by Condition

Alzheimers Disease TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN